Jian is a seasoned commercial leader with more than 30 years of pharmaceutical experience across the US, Asia, and Europe. During his 22-year tenure at Eli Lilly, he built a reputation for deep insight into global market dynamics and a proven ability to identify value drivers in highly competitive, evolving environments. As a member of the Clickspring Collective, Jian can partner with biotech clients to define target asset profiles and maximize asset value through tailored development strategies.

A pharmacist by training, Jian is widely respected and frequently sought out by medical, regulatory, and scientific leaders for his strategic perspective. His exceptional understanding of science, clinical study design, and the commercial implications of development decisions enables him to bridge disciplines and align cross-functional teams around clear, value-driven strategies.

A recognized expert in early-phase commercial development, Jim led strategic planning for Lilly’s cardiometabolic pipeline. He guided multiple assets from early development through Phase 3 trials and ultimately leading teams to build a winning brand strategy. He played a critical role transforming a modest profile improvement asset into a blockbuster. He also led the team to build the largest pharmaceutical brands, fundamentally transforming the category.

Originally from China, Jian has lived in the US for over 25 years. He enjoys travel, landscape photography, and spending time with his wife Qi and daughter Yiling.